These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15628355)

  • 41. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
    Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
    Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
    Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis.
    Huang QL; Qian ZX; Li H
    Hepatogastroenterology; 2010; 57(102-103):1295-9. PubMed ID: 21410075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trypsin-based laboratory methods and carboxypeptidase activation peptide in acute pancreatitis.
    Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P
    JOP; 2002 Mar; 3(2):34-48. PubMed ID: 11884765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical laboratory assessment of acute pancreatitis.
    Al-Bahrani AZ; Ammori BJ
    Clin Chim Acta; 2005 Dec; 362(1-2):26-48. PubMed ID: 16024009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urinary trypsinogen activation peptide (TAP)].
    Naruse S
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():131-2. PubMed ID: 15628355
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism and role of trypsinogen activation in acute pancreatitis.
    Mayer J; Rau B; Schoenberg MH; Beger HG
    Hepatogastroenterology; 1999; 46(29):2757-63. PubMed ID: 10576341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What are the predictors of post-ERCP pancreatitis, and how useful are they?
    Sultan S; Baillie J
    JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness.
    Frossard JL
    JOP; 2001 Mar; 2(2):69-77. PubMed ID: 11867866
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.